The Hepatitis B Virus-Specific CTL Responses Induced in Humans by Lipopeptide Vaccination Are Comparable to Those Elicited by Acute Viral Infection

Journal of Immunology

Volumn 159, Issue 3, 1997, Pages 1383-1392

  Livingston, Brian D ^a   Crimi, Claire ^a   Grey, Hilda ^a   Ishioka, Glenn ^a   Chisari, Francis V ^b   Fikes, John ^a   Grey, Howard ^a   Chesnut, Robert W ^a   Sette, Alessandro ^a  

^a CYTEL CORPORATION   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPATITIS B VACCINE; HLA A2 ANTIGEN; LIPOPROTEIN; PEPTIDE FRAGMENT; RECOMBINANT VACCINE; THERADIGM HBV; THERADIGM-HBV;

ACUTE DISEASE; ADULT; AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFLUENZA VIRUS A; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MOLECULAR GENETICS; STEM CELL;

ACUTE DISEASE; ADULT; AMINO ACID SEQUENCE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HLA-A2 ANTIGEN; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; STEM CELLS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, SYNTHETIC;

EID: 0031204408     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Penna, A., F. V. Chisari, A. Bertoletti, G. Missale, P. Fowler, T. Guiberti, F. Fiaccadori, and C. Ferrari. 1991. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis nucleocapsid antigen. J. Exp. Med. 174: 1565.
2. Nayersina, R., P. Fowler, S. Guilhot, G. Missale, A. Cerny, H. J. Schlicht, A. Vitiello, R. Chesnut, J. L. Person, A. G. Pedekee, and F. V. Chisari. 1993. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659.
3. Perrillo, R. P. 1989. Treatment of chronic hepatitis with interferon: experience in Western countries. Semin. Liver Dis. 9:240.
4. Guidotti, L. G., K. Ando, M. V. Hobbs, T. Ishikawa, L. Runkel, R. D. Schreiber, and F. V. Chisari. 1994. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA 913764.
5. Vitiello, A., G. Ishioka, H. M. Grey, R. Rose, P. Farness, R. LaFond, L. Yuan, F. V. Chisari, J. Furze, R. Bartholomeuz, and R. W. Chesnut. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. J. Clin. Invest. 95341.
6. Panina-Bordignon, P., A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia. 1989. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237.
7. Rupert, J., J. Sidney, E. Celis, R. T. Kubo, H. M. Grey, and A. Sette. 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929.
8. del Guercio, M.-F., J. Sidney, G. Hermanson, C. Perez, H. M. Grey, R. T. Kubo, and A. Sette. 1994. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:685.
9. Wentworth, P. A., E. Celis, C. Crimi, S. Stitley, L. Hale, V. Tsai, H. M. Serra, M.-F. del Guercio, B. Livingston, D. Alazard, J. Fikes, R. Kubo, H. M. Grey, R. W. Chesnut, F. V. Chisari, and A. Sette. 1995. In vitro induction of primary antigen specific CTL from human PBMC stimulated with synthetic peptides. Mol. Immunol. 32:603.
10. McMichael, A. J., F. M. Gotch, J. Santos-Aguado, and J. L. Strominger. 1988. Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 85:9194.
11. Celis E., V. Tsai, C. Crimi, R. DeMars, P. A. Wentworth, R. W. Chesnut, H. M. Grey, A. Sette, and H. M. Serra. 1994. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA 91:2105.
12. Guilhot, S., P. Fowler, G. Portillo, R. F. Margolskee, C. Ferrari, A. Bertoletti, and F. V. Chisari. 1992. Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines. J. Virol. 66:2670.
13. Rehermann, B., D. Lau, J. H. Hoofnagle, and F. V. Chisari. 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J. Clin. Invest. 971655.
14. Fazekas, S., and S. T. Groth. 1982. The evaluation of limiting dilution assays. J. Immunol. Methods R11:R23.
15. Gotch, F., A. McMichael, and J. Rothbard. 1988. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes: use of analogues to orientate the matrix peptide in the HLA-A2 binding site. J. Exp. Med. 168: 2045.
16. Gotch, F., J. Rothbard, K. Howland, A. Townsend, and A. McMichael. 1987. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 326:881.
17. Gotch, F., A. McMichael, G. Smith and B. Moss. 1987. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J. Exp. Med. 165:408.
18. + cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353:180.
19. + T cell help. J. Immunol. 147:4069.
20. Perkins, D. L., G. Berriz, T. Kamradt, J. A. Smith, and M. L. Gefter. 1991. Immunodominance: intramolecular competition between T cell epitopes. J. Immunol. 146:2137.
21. Wang, Y., J. A. Smith, T. Kamradt, M. L. Gefter and D. L. Perkins. 1992. Silencing of immunodominant epitopes by contiguous sequences in complex synthetic peptides. Cell. Immunol. 143:284.
22. Wang, Y., J. A. Smith, M. L. Gefter, and D. L. Perkins. 1992. Immunodominance: intermolecular competition between MHC class II molecules by covalently linked T cell epitopes. J. Immunol. 148:3034.
23. Suazet, J., H. Gras-Masse, J. Guillet, and E. Gomard. 1996. Influence of strong CD4 epitope on long-term virus specific cytotoxic T cell responses induced in vivo with peptide. Int. Immunol. 8457.
24. Kundig, T. M., M. F. Bachmann, P. S. Ohashi, H. Pircher, H. Hengartner, and R. M. Zinkernagel. 1996. On T cell memory: arguments for antigen dependence. Immunol. Rev 15063.
25. Lau, L. L., B. D. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell memory without antigen. Nature 369:648.
26. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54.
27. Dienstag, I. L., R. P. Perillo, E. R. Schiff, M. Bartholomew, C. Vieary, and M. Robin. 1995. A preliminary trial of Lamivudine for chronic hepatitis B infection. N. Engl. J. Med. 333:1657.
28. Perales, M.-A., D. H. Schwartz, J. A. Fabry, and J. Lieberman. 1995. A vaccinia gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocyte in some HIV-1 seronegative vaccines. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10:27.
29. Scalzo, A. A., S. L. Elliott, J. Cox, J. Gardner, D. J. Moss, and A. Suhrbier. 1995. Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720). J. Virol. 69:1306.
30. Egan, M. A., W. A. Pavlat, J. Tartaglia, E. Paoletti, K. J. Weinhold, M. L. Clements, and R. F. Siliciano. 1995. Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-limited canarypox vector (ALVAC) carrying the HIV-1 MN env gene. J. Infect. Dis. 171:1623.
31. Glenny, A. T., G. A. H. Buttle, and M. F. Stevens. Rate of disappearance of diphtheria toxin injected into rabbits and guinea pigs. J. Pathol. Bacteriol. 34: 267.
32. Braun, V. 1975. Covalent lipoprotein from the outer membrane of Escherichia coli. Biochim. Biophys. Acta 415:335.
33. Deres, K., H. Schild, K. H. Wiesmuller, G. Jung, and H. G. Rammensee. 1989. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 342:561.
34. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12991.
35. Carbone, F. R., and M. J. Bevan. 1990. Class I-restricted processing and presentation of exogenous cell-associated antigens in vivo. J. Exp. Med. 171:377.
36. Rock, K. L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17:131.
37. + T cells but affect their long-term life span. Immunity 5::217.
38. Sidney, J., H. M. Grey, R. T. Kubo, and A. Sette. 1996. Practical, biochemical, and evolutionary implications of the discovery of HLA class I supermotifs. Immunol. Today 17:261.